Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Central Nervous System - Dementia Drug Pipeline Report' returned 175 results - Page 1 of 9   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Central Nervous System - Pain Drug Pipeline Report   Life Science Analytics, June 2007, Pages: 27 Life Science Analytics, "Central Nervous System - Pain Drug Pipeline Report" contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of pain Central Nervous System - Parkinson Disease Drug Pipeline Report   Life Science Analytics, June 2007, Pages: 18 Life Science Analytics, "Central Nervous System - Parkinson Disease Drug Pipeline Report" contains detailed information on the current drug pipeline. This report provides insight into the pipeline Central Nervous System - Schizophrenia Drug Pipeline Report   Life Science Analytics, June 2007, Pages: 20 Life Science Analytics, "Central Nervous System - Schizophrenia Drug Pipeline Report" contains detailed information on the current drug pipeline. This report provides insight into the pipeline Central Nervous System - Migraine Drug Pipeline Report   Life Science Analytics, June 2007, Pages: 19 Life Science Analytics, "Central Nervous System - Migraine Drug Pipeline Report" contains detailed information on the current drug pipeline. This report provides insight into the pipeline status Central Nervous System - Seizures Drug Pipeline Report   Life Science Analytics, June 2007, Pages: 9 Life Science Analytics, "Central Nervous System - Seizures Drug Pipeline Report" contains detailed information on the current drug pipeline. This report provides insight into the pipeline status Central Nervous System - Multiple Sclerosis Drug Pipeline Report   Life Science Analytics, June 2007, Pages: 31 Life Science Analytics, "Central Nervous System - Multiple Sclerosis Drug Pipeline Report" contains detailed information on the current drug pipeline. This report provides insight into the pipeline Central Nervous System - Stroke Drug Pipeline Report   Life Science Analytics, June 2007, Pages: 12 Life Science Analytics, "Central Nervous System - Stroke Drug Pipeline Report" contains detailed information on the current drug pipeline. This report provides insight into the pipeline status Central Nervous System - Neuropathy Drug Pipeline Report   Life Science Analytics, June 2007, Pages: 13 Life Science Analytics, "Central Nervous System - Neuropathy Drug Pipeline Report" contains detailed information on the current drug pipeline. This report provides insight into the pipeline status Central Nervous System - Insomnia or Sleep Disorders Drug Pipeline Report   Life Science Analytics, June 2007, Pages: 14 Life Science Analytics, "Central Nervous System - Insomnia or Sleep Disorders Drug Pipeline Report" contains detailed information on the current drug pipeline. This report provides insight Endpoints - Clinical Trials in CNS Disorders - Multiple Endpoints and Ratings Scales are Becoming More Widely Adopted   GBI Research, Nov 2011, Pages: 216 Widely Adopted” which provides an insight into different endpoints that are used for the central nervous system (CNS) in clinical trials. The report examines different aspects under clinical trial Drug Discovery and Preclinical Molecules by Therapy Area - Innovation Focuses on Stem Cell Therapies and Gene Therapies   GBI Research, Feb 2011, Pages: 209 This report provides an in-depth analysis of the unmet needs, drivers and barriers that affect the global Central Nervous System Disorders (CNS), Metabolic Disorders, Immunologic Disorders Early Stage Drug Discovery in Disease Segments - Innovation Focuses on Stem Cell Therapies and Gene Therapies   GBI Research, Feb 2011, Pages: 209 to Pharmaceutical Companies 27 5.1 Drug Discovery & Development Process 27 5.1.1 Drug Discovery Process 27 6 Early Stage Drug Discovery in Therapeutic Segments 28 6.1 Central Nervous System Disorders 31 6 Innovations in Protein Kinase Therapies - Significant Proportion of Protein Kinase Pipeline Contains Small Molecule Drugs That Target Oncology   GBI Research, May 2011, Pages: 119 .4.1 Introduction 36 4.4.2 Pipeline Analysis 36 4.5 Central Nervous System 39 4.5.1 Introduction 39 4.5.2 Pipeline Analysis 40 4.6 Cardiovascular Diseases 44 4.6.1 Introduction 44 4.6.2 Pipeline Analysis 44 4 Oral Drug Delivery Market - Controlled and Sustained Release to be Major Revenue Generators   GBI Research, Nov 2010, Pages: 85 Systems 9.5 Central Nervous System 9.5.1 Analysis of the Global Migraine Therapeutics Market and Applications of Oral Drug Delivery Systems 9.5.2 Analysis of the Global Parkinson’s Disease Therapeutics Stroke_Central Nervous System Therapy Area Pipeline Report   Life Science Analytics, March 2009, Pages: 123 Life Science Analytics, Stroke_Central Nervous System Therapy Area Pipeline Report contains detailed information on the stroke - central nervous system drug pipeline. This report provides insight Comparative Analysis of Late Stage Pipeline Molecules in Major Indications - Oncology Pipeline Leads with Most Promising Molecules in Late Stage Development   GBI Research, July 2011, Pages: 132 disorders and central nervous system disorders. Oncology accounts for the majority of pipeline activity, with 37% of the entire pipeline. The focus on oncology to develop novel anti-cancer drugs is driven Acute Lymphocytic Leukemia - Unmet Needs in Adult and Pediatric Populations Drive Recent Market Developments   Decision Resources, Inc., June 2010, Pages: 44 ) and Sprycel (Dasatinib) -- Central Nervous System Prophylaxis - Drug Resistance - Stem Cell Transplantation -- Myeloablative Regimens -- Allogeneic Stem Cell Transplantation -- Autologous Stem Cell Licensing Opportunities: Neurology   Decision Resources, Inc., April 2010, Pages: 35 , and explored potential opportunities. Questions Answered in This Report: - In 2008, the central nervous system (CNS) market was the second largest therapy market (after the top-ranked cardiovascular Pharmaceutical Industry - 2010 Yearbook - Therapeutic Market Landscape, Key Pipeline Drugs, Top Pharma Companies and Key Mergers and Acquisitions   GBI Research, Dec 2010, Pages: 177 of the major trends and issues affecting the Pharmaceutical market. The report provides a comprehensive insight into the history of Pharmaceutical Industry Therapeutic Market Landscape, Key Pipeline Drugs, Top Pain Therapeutics - Drugs, Markets and Companies   Jain PharmaBiotech, Feb 2012, Pages: 532 in the central nervous system Opioid receptors Role of AMPA receptors in chronic pain Kinins Serotonin Substance P Excitatory amino acids Role of nitric oxide in pain Prostaglandins Endocannabinoids Results:  First -   Prev -   1 -   2 -   3 -   4 -   5 -   6 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets3    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network